skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 457  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Postprandial Hyperlipidemia and Remnant Lipoproteins
Postprandial Hyperlipidemia and Remnant Lipoproteins
Material Type:
Article 		Add to My Research

Postprandial Hyperlipidemia and Remnant Lipoproteins

Journal of Atherosclerosis and Thrombosis, 2017/02/01, Vol.24(2), pp.95-109

2017 This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License. ;2017 Japan Atherosclerosis Society 2017 ;ISSN: 1340-3478 ;EISSN: 1880-3873 ;DOI: 10.5551/jat.RV16003 ;PMID: 27829582

Full text available

Citations Cited by
2
Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity
Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity
Material Type:
Article 		Add to My Research

Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity

Nature reviews. Endocrinology, 2020-03, Vol.16 (3), p.177-189 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1759-5029 ;EISSN: 1759-5037 ;DOI: 10.1038/s41574-019-0310-7 ;PMID: 32020062

Full text available

Citations Cited by
3
Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017
Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017
Material Type:
Article 		Add to My Research

Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017

Journal of Atherosclerosis and Thrombosis, 2018/08/01, Vol.25(8), pp.751-770

2018 This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License. ;2018 Japan Atherosclerosis Society 2018 ;ISSN: 1340-3478 ;EISSN: 1880-3873 ;DOI: 10.5551/jat.CR003 ;PMID: 29877295

Full text available

Citations Cited by
4
Serum HDL-Cholesterol Level Does Not Influence Cardiovascular Event Rate under Sufficient Lowering of LDL-Cholesterol by Pitavatatin in Patients with Stable Coronary Artery Disease
Serum HDL-Cholesterol Level Does Not Influence Cardiovascular Event Rate under Sufficient Lowering of LDL-Cholesterol by Pitavatatin in Patients with Stable Coronary Artery Disease
Material Type:
Article 		Add to My Research

Serum HDL-Cholesterol Level Does Not Influence Cardiovascular Event Rate under Sufficient Lowering of LDL-Cholesterol by Pitavatatin in Patients with Stable Coronary Artery Disease

Journal of Atherosclerosis and Thrombosis, 2022/01/01, Vol.29(1), pp.8-10

This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License. ;2022 Japan Atherosclerosis Society 2022 ;ISSN: 1340-3478 ;EISSN: 1880-3873 ;DOI: 10.5551/jat.ED165 ;PMID: 33762513

Full text available

Citations Cited by
5
Guidance for Pediatric Familial Hypercholesterolemia 2017
Guidance for Pediatric Familial Hypercholesterolemia 2017
Material Type:
Article 		Add to My Research

Guidance for Pediatric Familial Hypercholesterolemia 2017

Journal of Atherosclerosis and Thrombosis, 2018/06/01, Vol.25(6), pp.539-553

2018 This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License. ;2018 Japan Atherosclerosis Society 2018 ;ISSN: 1340-3478 ;EISSN: 1880-3873 ;DOI: 10.5551/jat.CR002 ;PMID: 29415907

Full text available

Citations Cited by
6
Adiposity measures and mortality in an Asian population
Adiposity measures and mortality in an Asian population
Material Type:
Article 		Add to My Research

Adiposity measures and mortality in an Asian population

Nature reviews. Endocrinology, 2021-02, Vol.17 (2), p.69-70 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Springer Nature Limited 2020. ;ISSN: 1759-5029 ;EISSN: 1759-5037 ;DOI: 10.1038/s41574-020-00446-1 ;PMID: 33204034

Full text available

Citations Cited by
7
Recent Advances in Analytical Methods on Lipoprotein Subclasses: Calculation of Particle Numbers from Lipid Levels by Gel Permeation HPLC Using “Spherical Particle Model”
Recent Advances in Analytical Methods on Lipoprotein Subclasses: Calculation of Particle Numbers from Lipid Levels by Gel Permeation HPLC Using “Spherical Particle Model”
Material Type:
Article 		Add to My Research

Recent Advances in Analytical Methods on Lipoprotein Subclasses: Calculation of Particle Numbers from Lipid Levels by Gel Permeation HPLC Using “Spherical Particle Model”

Journal of Oleo Science, 2016, Vol.65(4), pp.265-282

2016 by Japan Oil Chemists' Society ;ISSN: 1345-8957 ;EISSN: 1347-3352 ;DOI: 10.5650/jos.ess16020

Full text available

Citations Cited by
8
New Horizons for Probucol, an Old, Mysterious Drug
New Horizons for Probucol, an Old, Mysterious Drug
Material Type:
Article 		Add to My Research

New Horizons for Probucol, an Old, Mysterious Drug

Journal of Atherosclerosis and Thrombosis, 2021/02/01, Vol.28(2), pp.100-102

2021 This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License. ;2021 Japan Atherosclerosis Society 2021 ;ISSN: 1340-3478 ;EISSN: 1880-3873 ;DOI: 10.5551/jat.ED132 ;PMID: 32507832

Full text available

Citations Cited by
9
Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan —2012 Version
Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan —2012 Version
Material Type:
Article 		Add to My Research

Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan —2012 Version

Journal of Atherosclerosis and Thrombosis, 2013, Vol.20(6), pp.517-523

2013 Japan Atherosclerosis Society ;ISSN: 1340-3478 ;EISSN: 1880-3873 ;DOI: 10.5551/jat.15792 ;PMID: 23665881

Full text available

Citations Cited by
10
Postprandial Glucose and Triglyceride Increases Along with the Endothelial Malfunction were Attenuated by the Administration of SGLT2 Inhibitor, Empagliflozin
Postprandial Glucose and Triglyceride Increases Along with the Endothelial Malfunction were Attenuated by the Administration of SGLT2 Inhibitor, Empagliflozin
Material Type:
Article 		Add to My Research

Postprandial Glucose and Triglyceride Increases Along with the Endothelial Malfunction were Attenuated by the Administration of SGLT2 Inhibitor, Empagliflozin

Journal of Atherosclerosis and Thrombosis, 2020/07/01, Vol.27(7), pp.637-638

2020 This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License. ;2020 Japan Atherosclerosis Society 2020 ;ISSN: 1340-3478 ;EISSN: 1880-3873 ;DOI: 10.5551/jat.ED124 ;PMID: 32009076

Full text available

Citations Cited by
11
Current Diagnosis and Management of Tangier Disease
Current Diagnosis and Management of Tangier Disease
Material Type:
Article 		Add to My Research

Current Diagnosis and Management of Tangier Disease

Journal of Atherosclerosis and Thrombosis, 2021/08/01, Vol.28(8), pp.802-810

This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License. ;2021 Japan Atherosclerosis Society 2021 ;ISSN: 1340-3478 ;EISSN: 1880-3873 ;DOI: 10.5551/jat.RV17053 ;PMID: 33994407

Full text available

Citations Cited by
12
Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care
Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care
Material Type:
Article 		Add to My Research

Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care

Nature reviews cardiology, 2020-06, Vol.17 (6), p.360-377 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;Springer Nature Limited 2020. ;ISSN: 1759-5002 ;EISSN: 1759-5010 ;DOI: 10.1038/s41569-019-0325-8 ;PMID: 31974482

Full text available

Citations Cited by
13
Diagnosis and Management of Sitosterolemia 2021
Diagnosis and Management of Sitosterolemia 2021
Material Type:
Article 		Add to My Research

Diagnosis and Management of Sitosterolemia 2021

Journal of Atherosclerosis and Thrombosis, 2021/08/01, Vol.28(8), pp.791-801

This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License. ;2021 Japan Atherosclerosis Society 2021 ;ISSN: 1340-3478 ;EISSN: 1880-3873 ;DOI: 10.5551/jat.RV17052 ;PMID: 33907061

Full text available

Citations Cited by
14
Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Material Type:
Article 		Add to My Research

Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial

Journal of Atherosclerosis and Thrombosis, 2018/06/01, Vol.25(6), pp.521-538

2018 This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License. ;2018 Japan Atherosclerosis Society 2018 ;ISSN: 1340-3478 ;EISSN: 1880-3873 ;DOI: 10.5551/jat.44412 ;PMID: 29628483

Full text available

Citations Cited by
15
Reference Intervals of Serum Non-Cholesterol Sterols by Gender in Healthy Japanese Individuals
Reference Intervals of Serum Non-Cholesterol Sterols by Gender in Healthy Japanese Individuals
Material Type:
Article 		Add to My Research

Reference Intervals of Serum Non-Cholesterol Sterols by Gender in Healthy Japanese Individuals

Journal of Atherosclerosis and Thrombosis, 2020/05/01, Vol.27(5), pp.409-417

2020 This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License. ;2020 Japan Atherosclerosis Society 2020 ;ISSN: 1340-3478 ;EISSN: 1880-3873 ;DOI: 10.5551/jat.50187 ;PMID: 31484845

Full text available

Citations Cited by
16
Anti-GPIHBP1 Antibody-Positive Autoimmune Hyperchylomicronemia and Immune Thrombocytopenia
Anti-GPIHBP1 Antibody-Positive Autoimmune Hyperchylomicronemia and Immune Thrombocytopenia
Material Type:
Article 		Add to My Research

Anti-GPIHBP1 Antibody-Positive Autoimmune Hyperchylomicronemia and Immune Thrombocytopenia

Journal of Atherosclerosis and Thrombosis, 2023/01/01, Vol.30(1), pp.100-104

This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License. ;2023 Japan Atherosclerosis Society 2023 ;ISSN: 1340-3478 ;EISSN: 1880-3873 ;DOI: 10.5551/jat.63348 ;PMID: 35185060

Full text available

Citations Cited by
17
Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study
Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study
Material Type:
Article 		Add to My Research

Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study

Journal of Atherosclerosis and Thrombosis, 2022/05/01, Vol.29(5), pp.608-638

This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License. ;2022 Japan Atherosclerosis Society 2022 ;ISSN: 1340-3478 ;EISSN: 1880-3873 ;DOI: 10.5551/jat.62764 ;PMID: 33980760

Full text available

Citations Cited by
18
Achievement Rates for Low-Density Lipoprotein Cholesterol Goals in Patients at High Risk of Atherosclerotic Cardiovascular Disease in a Real-World Setting in Japan
Achievement Rates for Low-Density Lipoprotein Cholesterol Goals in Patients at High Risk of Atherosclerotic Cardiovascular Disease in a Real-World Setting in Japan
Material Type:
Article 		Add to My Research

Achievement Rates for Low-Density Lipoprotein Cholesterol Goals in Patients at High Risk of Atherosclerotic Cardiovascular Disease in a Real-World Setting in Japan

Journal of Atherosclerosis and Thrombosis, 2023/11/01, Vol.30(11), pp.1622-1634

This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License. ;2023 Japan Atherosclerosis Society 2023 ;ISSN: 1340-3478 ;EISSN: 1880-3873 ;DOI: 10.5551/jat.63940 ;PMID: 36928267

Full text available

Citations Cited by
19
Effects of Evolocumab (AMG 145), a Monoclonal Antibody to PCSK9, in Hypercholesterolemic, Statin-Treated Japanese Patients at High Cardiovascular Risk: Primary Results From the Phase 2 YUKAWA Study
Effects of Evolocumab (AMG 145), a Monoclonal Antibody to PCSK9, in Hypercholesterolemic, Statin-Treated Japanese Patients at High Cardiovascular Risk: Primary Results From the Phase 2 YUKAWA Study
Material Type:
Article 		Add to My Research

Effects of Evolocumab (AMG 145), a Monoclonal Antibody to PCSK9, in Hypercholesterolemic, Statin-Treated Japanese Patients at High Cardiovascular Risk: Primary Results From the Phase 2 YUKAWA Study

Circulation Journal, 2014, Vol.78(5), pp.1073-1082 [Peer Reviewed Journal]

2014 THE JAPANESE CIRCULATION SOCIETY ;ISSN: 1346-9843 ;EISSN: 1347-4820 ;DOI: 10.1253/circj.CJ-14-0130 ;PMID: 24662398

Full text available

Citations Cited by
20
Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment
Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment
Material Type:
Article 		Add to My Research

Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment

International journal of molecular sciences, 2019-02, Vol.20 (3), p.706 [Peer Reviewed Journal]

2019. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 by the authors. 2019 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms20030706 ;PMID: 30736366

Full text available

Citations Cited by

Results 1 - 20 of 457  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (243)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1992  (18)
  2. 1992 To 1999  (53)
  3. 2000 To 2007  (75)
  4. 2008 To 2016  (131)
  5. After 2016  (181)
  6. More options open sub menu

Resource Type 

  1. Articles  (438)
  2. Patents  (18)
  3. Reports  (1)
  4. More options open sub menu

Language 

  1. English  (433)
  2. Japanese  (171)
  3. French  (9)
  4. German  (4)
  5. Chinese  (1)
  6. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait